News
University of Arizona Department of Urology faculty member Dr. Sunchin Kim and general urology nurse practitioner Cara Whittingham will provide patient care at the Cortaro Road Banner clinic in Tucson.
The tele-ultrasound training program for lung point-of-care ultrasound (POCUS) will enable rural emergency departments to more effectively identify and treat suspected COVID-19 patients.
The university is currently allowing courses of up to 50 students to meet on campus. After Thanksgiving, all courses will transition to being fully online.
Two faculty members inducted to National Academy of Inventors, ‘Gut Group’ team wins $250,000 for gastrointestinal cancer research, Dr. Chalasani wins NCI team leadership award, and new physicians join as pediatrics, infectious disease specialists.
The University of Arizona has licensed new radio-labeling chemistry for PET contrast agents to startup TheraCea Pharma.
The Arizona portion of an 11-state effort, funded by a $12 million federal award, to address the uneven impact of the pandemic on racial and ethnic minority communities will be led by the UArizona Health Sciences.
A new diagnostic test for coronavirus relies on gargling with saltwater instead of using a nasal swab. Initial results have been encouraging, UArizona virology expert Dr. Michael Worobey says.
The university remains in stage two of its reentry plan this week, with classes of up to 50 students given the option to meet on campus.
With UArizona faculty appointments in the Departments of Pediatrics and Otolaryngology - Head and Neck Surgery, Dr. Jonathan Skirko will provide clinical care in advanced pediatric ear, nose and throat medicine at Banner Children’s – Diamond Children’s.
A microRNA that can be found in a blood sample may make it easier to detect gastric cancer and could lead to improved treatment for diseases that are resistant to common immunotherapies.
The contribution will allow UArizona researchers to continue developing better, more efficient and effective tests for people across the state.
The university also will conduct a testing blitz prior to the Thanksgiving holiday in an effort to reduce travel-related spread of COVID-19.
Researchers developed one of the most accurate COVID-19 antibody tests available and now have shown antibodies persist for months after infection, providing long-term immunity.
The university will expand in-person instruction with half the semester left to go, bringing about 1,500 more students to campus a week.
The $2.3 million National Institutes of Health grant will enable Dr. Alicia Allen to explore how women’s hormones influence postpartum opioid relapse and if they may be used as a preventative strategy.
University of Arizona Cancer Center researcher Dr. Daniel Persky led a study that found many patients with the most common type of non-Hodgkin’s lymphoma, diffuse large B-cell lymphoma (DLBCL), can safely skip radiation and receive fewer chemotherapy treatments.
On Oct. 12, the university hopes to resume in-person instruction for classes of 30 or fewer students that were designated in-person or flex in-person courses at the time of registration.
The new faculty cardiologists, Drs. Keng Pineda and Andrew Williams, bring expertise in interventional cardiology, cardiac imaging, cardio-oncology and sports cardiology to the University of Arizona Health Sciences and Banner – University Medicine Tucson.
As more older adults use smartphones, College of Pharmacy researcher Dr. Jeannie Lee hopes to improve medication adherence and blood pressure rates with a management system in the palm of their hand.
Antibodies normally fight viruses, but in the case of flaviviruses, they can make infections worse. Researchers took a closer look at antibody production to figure out why.